Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20240727062550N1Phase 3Completed
Phase 3, open-label trial of fentanyl (2 arms), sponsored by Islamic Azad University. Primary endpoint: Systolic blood pressure. Started Aug 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20240727062550N1.